ADx NeuroSciences
0839.400.980 · rovalta.com · 24/09/2026
ACTIVE
ADx NeuroSciences
Financial year 2026 · Closed on 31/03/2026
Net result-380,1 k €+27,6 %over 1 year
Gross margin1,6 M €+77,4 %over 1 year
Equity4,2 M €-8,3 %over 1 year
Workforce18,8 ETP+13,9 %over 1 year
Overview
Identity
Source · BCE/KBOADx NeuroSciences is a Public limited company incorporated in 2011. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Gent. It employs on average 18,8 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0839.400.980
- Incorporation
- 16/09/2011
- Legal form
- Public limited company
- Registered office
- Technologiepark-Zwijnaarde 6
9052 Gent · FlandreSee on map - Contributed capital
- 5 209 800,00 €
- Latest accounts
- 31/03/2026
- Average workforce
- 18,8 ETP
Activities (NACE)
Joint committees (3)
- 200
- 207
- 218
Signals
Solid equityLow riskGood liquidityHealthy social debts
Financials
Source · NBB, 15 filingsTrend over 12 financial years
| 2026 | 2025 | 2024 | 2023 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 1,6 M € | +77.4% | 911,7 k € | -65.4% | 2,6 M € | -11.4% | 3 M € | +36.4% | 2,2 M € |
| EBITDA | -163,8 k € | +74.2% | -634,6 k € | -151% | 1,3 M € | -14.5% | 1,5 M € | +46.1% | 1 M € |
| Operating result | -354,7 k € | +50.5% | -717,1 k € | -161% | 1,2 M € | -14.6% | 1,4 M € | +47.2% | 938,9 k € |
| Net result | -380,1 k € | +27.6% | -525,1 k € | -142% | 1,3 M € | -9.3% | 1,4 M € | +47.5% | 938,6 k € |
| Balance sheet | |||||||||
| Equity | 4,2 M € | -8.3% | 4,6 M € | -10.3% | 5,1 M € | +32.5% | 3,9 M € | +90.2% | 2 M € |
| Total assets | 4,9 M € | -16.8% | 5,9 M € | +0.5% | 5,8 M € | +23.8% | 4,7 M € | +55.7% | 3 M € |
| Cash | 223,7 k € | -46.0% | 414,2 k € | +6.5% | 389 k € | -5.5% | 411,7 k € | -72.1% | 1,5 M € |
| Debts | 485,1 k € | -56.9% | 1,1 M € | +62.0% | 695,4 k € | -11.7% | 787,9 k € | +37.8% | 571,9 k € |
| Other | |||||||||
| Workforce | 18,8 ETP | +13.9% | 16,5 ETP | +5.1% | 15,7 ETP | +6.8% | 14,7 ETP | +1.4% | 14,5 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/03/20266 active · 34 ended
Active mandates
Kurt Troch
ActiveTadashi Ninomiya
ActiveActive
Goki Ishikawa
ActiveKoji Aoki
ActiveActive
Ended mandates
Other companies at this address
Technologiepark-Zwijnaarde 6 9052 Gent| Company | CBE no. |
|---|---|
FujiADx● Active | 1004.979.782 |
FUJIREBIO EUROPE● Active | 0427.550.660 |
Financials
Full financial information
Source · NBB| 2026 | 2025 | 2024 | 2023 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/04/2025 | 01/04/2024 | 01/04/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 15 months | 12 months | 12 months |
| Filing date | 31/07/2026 | 08/10/2025 | 27/08/2024 | 08/11/2023 | 24/10/2023 | 18/06/2021 |
| General meeting | 29/07/2026 | 04/09/2025 | 31/07/2024 | 13/10/2023 | 13/10/2023 | 21/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 15 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/03/2026 | 29/07/2026 | 31/07/2026 | Dutch | |
| Abridged model | 31/03/2025 | 04/09/2025 | 08/10/2025 | Dutch | |
| Abridged model | 31/03/2024 | 31/07/2024 | 27/08/2024 | Dutch | |
| Abridged model | 31/03/2023 | 13/10/2023 | 08/11/2023 | Dutch | |
| Abridged modelCorrection | 31/12/2021 | 13/10/2023 | 24/10/2023 | Dutch | |
| Abridged model | 31/12/2021 | 13/05/2022 | 18/05/2022 | Dutch | |
| Abridged model | 31/12/2020 | 21/05/2021 | 18/06/2021 | Dutch | |
| Abridged model | 31/12/2019 | 08/05/2020 | 18/05/2020 | Dutch | |
| Abridged model | 31/12/2018 | 24/05/2019 | 29/05/2019 | Dutch | |
| Abridged model | 31/12/2017 | 18/05/2018 | 14/06/2018 | Dutch | |
| Abridged model | 31/12/2016 | 12/05/2017 | 18/05/2017 | Dutch | |
| Abridged model | 31/12/2015 | 13/05/2016 | 17/05/2016 | Dutch | |
| Abridged model | 31/12/2014 | 21/05/2015 | 27/05/2015 | Dutch | |
| Abridged model | 31/12/2013 | 09/05/2014 | 14/05/2014 | Dutch | |
| Abridged model | 31/12/2012 | 31/05/2013 | 20/06/2013 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/03/20266 active · 34 ended
Active mandates
Kurt Troch
ActiveTadashi Ninomiya
ActiveActive
Goki Ishikawa
ActiveKoji Aoki
ActiveActive
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Restructuring08/05/2026RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ... - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Restructuring19/02/2026KAPITAAL - AANDELEN - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Mandates10/09/2024ONTSLAGEN - BENOEMINGEN
- Registered office16/02/2024MAATSCHAPPELIJKE ZETEL
- Mandates25/04/2023ONTSLAGEN - BENOEMINGEN
- Other06/01/2023STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - ALGEMENE VERGADERING - BOEKJAAR
- Mandates17/08/2022ONTSLAGEN - BENOEMINGEN
- Capital / shares17/08/2022KAPITAAL - AANDELEN
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2026Annual accounts 2026-380,1 k €↑
- 2025Annual accounts 2025-525,1 k €↓
- 2024Annual accounts 20241,3 M €↓
- 2023Annual accounts 20231,4 M €↑
- 2021Annual accounts 2021938,6 k €↑
- 2018Annual accounts 2018-12,7 k €↑
- 2017Annual accounts 2017-438,1 k €↑
- 2016Annual accounts 2016-490,4 k €↓
- 2015Annual accounts 2015-142,4 k €↑
- 2014Annual accounts 2014-637,3 k €↑
- 2013Annual accounts 2013-937,9 k €↓
- 2012Annual accounts 2012-815,7 k €
- 16/09/2011IncorporationPublic limited company